What is the main difference between AOD-9604 and VK2735?

Both AOD-9604 and VK2735 are categorized under Metabolic, but they differ in evidence strength. AOD-9604 has Low evidence (20 sources), while VK2735 has Moderate evidence (12 sources).

Which has more clinical evidence, AOD-9604 or VK2735?

VK2735 has more clinical evidence with 11 human studies compared to 6 for AOD-9604. Overall, VK2735 has Moderate evidence strength while AOD-9604 has Low.

Are AOD-9604 and VK2735 FDA approved?

AOD-9604 has Low clinical evidence and is not FDA-approved for general use. VK2735 has moderate clinical evidence from human studies, though its regulatory status varies. Always verify current regulatory status with official sources.

Can AOD-9604 and VK2735 be combined?

There is no published research on combining AOD-9604 and VK2735. The safety and efficacy of any combination is unknown without clinical data.

Metabolic Comparison

AOD-9604 vs VK2735

Comparison of AOD-9604 (Low evidence) and VK2735 (Moderate evidence).

Last updated: February 12, 2026

AOD-9604

Low Evidence

View full dossier

VK2735

Moderate Evidence

View full dossier

Overview

AOD-9604 and VK2735 are both studied in the peptide research space.

AOD-9604: A modified fragment of human growth hormone (amino acids 176-191 with N-terminal tyrosine) studied for fat loss.

VK2735: A dual GLP-1/GIP receptor agonist from Viking Therapeutics with both subcutaneous and oral formulations.

Evidence Comparison

Aspect	AOD-9604	VK2735
Evidence Level	Low	Moderate
Human Studies	6	11
Preclinical Studies	8	1
Total Sources	20	12

Key Differences

Aspect	AOD-9604	VK2735
Category	Metabolic	Metabolic
Evidence Strength	Low	Moderate
Total Sources	20	12
Human Studies	6	11

Summary

AOD-9604: Low evidence with 20 total sources (6 human)
VK2735: Moderate evidence with 12 total sources (11 human)

This comparison is for educational purposes only and is not medical advice. Consult a healthcare professional before making any decisions about peptide use.

View Full Dossiers

AOD-9604 Evidence Dossier VK2735 Evidence Dossier

Stay Updated on Peptide Comparisons

Get notified when we publish new comparison dossiers and evidence reviews.

No spam. Unsubscribe anytime.

Disclaimer: This comparison is for educational purposes only and does not constitute medical advice. Individual responses to medications vary. Always consult a qualified healthcare provider before making treatment decisions.